Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8738)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 6, 2017 (publication date) through May 7, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Viola A, Costantino G, Privitera AC, Bossa F, Lauria A, Grossi L, Principi MB, Della Valle N, Cappello M. Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter study. World J Gastrointest Pharmacol Ther 2017; 8(2): 131-136 [PMID: 28533923 DOI: 10.4292/wjgpt.v8.i2.131] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v8/i2/131.htm |
| Number | Citing Articles |
| 1 |
Caroline Rusch, Marci Wood, Amanda G. Kennedy, Bradley J. Tompkins, Joseph D. Frasca. Rapid infusion of infliximab biosimilars and the incidence and severity of infusion‐related reactions in patients with inflammatory bowel disease. Journal of Clinical Pharmacy and Therapeutics 2022; 47(11): 1851 doi: 10.1111/jcpt.13779
|
| 2 |
Elsa A. van Wassenaer, Janneke P.M. van Oosterhout, Joost G. Daams, Merlijn J.M. van den Berg, Hanneke van der Lee, Geert R. D’Haens, Tim G.J. de Meij, Marc A. Benninga, Bart G.P. Koot. Safety of Rapid Infliximab Infusions in Children. Journal of Pediatric Gastroenterology and Nutrition 2020; 71(3): 361 doi: 10.1097/MPG.0000000000002815
|
| 3 |
Daniel M. O'Connell, Joshua Nachreiner, Xin Shu, Erica Terry, Taylor Imburgia, Joshua Vanderloo, Michael R. Lasarev, Monica Bogenschutz. Rapid Infliximab Biosimilar Infusion in Children With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2022; 74(5): 605 doi: 10.1097/MPG.0000000000003402
|
| 4 |
Antoinette Pusateri, Ashley Hatcher, Nisha Patel, Joy Lehman, Alice Hinton, Anita Afzali. Impact of rapid infliximab infusions on access at a large academic tertiary medical center. American Journal of Health-System Pharmacy 2021; 78(22): 2046 doi: 10.1093/ajhp/zxab225
|
| 5 |
Blake Rosenthal, Sabreen Aulakh, Perseus V Patel, Jason T Wong, Sabina Ali. Direct transition from rapid-infusion originator to rapid-infusion biosimilar tumor necrosis factor inhibitor in children with inflammatory bowel disease: A case series. American Journal of Health-System Pharmacy 2024; 81(2): 61 doi: 10.1093/ajhp/zxad217
|
| 6 |
Wan Chee Ong, Miao Shan Lim, Elaine Chan, Thomson Chong Teik Lim, Teong Guan Lim, Webber Chan. A quality improvement project reduces time spent at an inflammatory bowel disease infusion center with accelerated infliximab infusion protocol. JGH Open 2022; 6(7): 470 doi: 10.1002/jgh3.12776
|